» Articles » PMID: 33177842

Knockdown of LncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer Via Sponging MiR-1231

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2020 Nov 12
PMID 33177842
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pancreatic cancer ranks first among the most aggressive malignancies. Long non-coding RNA (LncRNA) ABHD11-AS1 is known to be upregulated in pancreatic cancer. However, the mechanism by which ABHD11-AS1 mediates the tumorigenesis of pancreatic cancer remains unclear.

Methods: Gene and protein expressions in pancreatic cancer cells were detected by qRT-PCR and Western blot, respectively. Cell viability was measured by CCK-8 assay. Cell apoptosis and cycle were tested by flow cytometry. In addition, cell migration and invasion were tested by wound healing and transwell assay, respectively. The correlation between ABHD11-AS1, miR-1231 and cyclin E1 was confirmed by dual-luciferase report and RNA pull-down. Finally, xenograft mice model was established to investigate the role of ABDH-AS1 in pancreatic cancer in vivo.

Results: ABHD11-AS1 was found to be negatively correlated with the survival rate of patients with pancreatic cancer. ABHD11-AS1 silencing significantly inhibited the proliferation and induced the apoptosis of pancreatic cancer cells. Additionally, knockdown of ABHD11-AS1 greatly inhibited the migration and invasion of pancreatic cancer cells. Meanwhile, ABHD11-AS1 bound to miR-1231 and cyclin E1 was found to be the target of miR-1231. Moreover, ABHD11-AS1 knockdown-induced G1 arrest in pancreatic cancer cells was reversed by miR-1231 antagomir. Finally, knockdown of ABHD11-AS1 obviously inhibited the tumor growth of pancreatic cancer in vivo.

Conclusion: ABHD11-AS1 silencing significantly inhibited the tumorigenesis of pancreatic cancer in vitro and in vivo. Thus, ABHD11-AS1 may serve as a potential target for the treatment of pancreatic cancer.

Citing Articles

Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway.

Tan S, Li S, Xia L, Jiang X, Ren Z, Peng Q Int J Oncol. 2025; 66(3).

PMID: 39950321 PMC: 11844336. DOI: 10.3892/ijo.2025.5726.


induces autophagic and apoptotic cell death in pancreatic cancer cells.

El Mahi Y, Nizami Z, Wali A, Al Neyadi A, Magramane M, Al Azzani M Front Pharmacol. 2024; 15:1412565.

PMID: 39139643 PMC: 11319293. DOI: 10.3389/fphar.2024.1412565.


The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy.

Pathania A, Chava H, Balusu R, Pasupulati A, Coulter D, Challagundla K Mol Ther Oncol. 2024; 32(2):200785.

PMID: 38595981 PMC: 10973673. DOI: 10.1016/j.omton.2024.200785.


[Long non-coding RNA ABHD11-AS1 promotes glycolysis in gastric cancer cells to accelerate tumor progression].

Feng W, Lai Y, Wang J, Xu P Nan Fang Yi Ke Da Xue Xue Bao. 2023; 43(9):1485-1492.

PMID: 37814862 PMC: 10563104. DOI: 10.12122/j.issn.1673-4254.2023.09.05.


METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot Study.

Huang G, Qiu Y, Fan Y, Liu J Neurochem Res. 2023; 49(1):85-98.

PMID: 37610605 DOI: 10.1007/s11064-023-04015-6.


References
1.
Zeng Y, Zhang Z, Wang W, You L, Dong X, Yin X . Underlying mechanisms of apoptosis in HepG2 cells induced by polyphyllin I through Fas death and mitochondrial pathways. Toxicol Mech Methods. 2020; 30(6):397-406. DOI: 10.1080/15376516.2020.1747125. View

2.
Dacheng W, Songhe L, Weidong J, Shutao Z, Jingjing L, Jiaming Z . RETRACTED: LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis. Biomed Pharmacother. 2020; 125:110039. DOI: 10.1016/j.biopha.2020.110039. View

3.
Liu X, Wang K, Du H . LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p. Eur Rev Med Pharmacol Sci. 2020; 24(14):7598-7611. DOI: 10.26355/eurrev_202007_22258. View

4.
Luo J, Yan S, Chen G, Chen P, Liang S, Xu Q . RNA-Sequencing, Connectivity Mapping, and Molecular Docking to Investigate Ligand-Protein Binding for Potential Drug Candidates for the Treatment of Wilms Tumor. Med Sci Monit. 2020; 26:e920725. PMC: 7119447. DOI: 10.12659/MSM.920725. View

5.
Zhuang X, Tong H, Ding Y, Wu L, Cai J, Si Y . Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis. Cell Death Dis. 2019; 10(8):620. PMC: 6692390. DOI: 10.1038/s41419-019-1850-4. View